JOSÉ
AGUARELES GORINES
Orientación Postdoctoral FPI
Pablo
Guisado Vasco
Pablo Guisado Vasco-rekin lankidetzan egindako argitalpenak (5)
2024
-
Outcomes and clinical characteristics of the compassionate use of plitidepsin in COVID-19 patients with solid tumours, haematological malignancies or anti-CD20 antibody treatment
Infectious Diseases, Vol. 56, Núm. 7, pp. 575-580
2023
-
Erratum: Flipped Inflammatory Time and the Role of Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2: Optimizing Tocilizumab Against Coronavirus Disease 2019 (Journal of Infectious Diseases (2022) 226 (1, 1-5) DOI: 10.1093/jid/jiac090)
Journal of Infectious Diseases
-
Outcomes and clinical characteristics of the compassionate use of plitidepsin for immunocompromised adult patients with COVID-19
International Journal of Infectious Diseases, Vol. 135, pp. 12-17
-
Use of Monoclonal Antibodies in Immunocompromised Patients Hospitalized with Severe COVID-19: A Retrospective Multicenter Cohort
Journal of Clinical Medicine, Vol. 12, Núm. 3